Achelois BioPharma has built a screening platform to discover T cell-intrinsic genetic-enhancing modifiers that enable tumor-specific T cells to eliminate established tumors in preclinical models and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback